DOI: 10.12890/2021_003004

Infected Cavitations, Bullae and Interstitial Lung Disease in a COVID-19 Patient in Lima, Peru

Authors

  • Francisco Arias Clínica Angloamericana, Lima, Peru
  • Alfredo Chiappe Clínica Angloamericana, Lima, Peru; Facultad de Medicina Humana, Universidad de Piura, Lima, Peru
  • Jorge Rey de Castro Clínica Angloamericana, Lima, Peru
  • Jorge Zagacet Clínica Angloamericana, Lima, Peru; Facultad de Medicina Humana, Universidad de Piura, Lima, Peru

francisco.arias.r@hotmail.com

Keywords

COVID-19 , cavitations, bullae, interstitial lung disease, pneumomediastinum

Abstract

A 48-year-old Peruvian man was diagnosed with COVID-19 in December 2020. His infection resolved and he was discharged from hospital after 14 days. However, 1 week later he presented with haemoptysis, malaise, pleuritic pain, infected cavitations, bullae, extensive interstitial lung disease and pneumomediastinum. He recovered after antibiotic treatment and was discharged after 8 days. His symptoms may have been due alveolar rupture due to persistent cough during and after diffuse inflammation of the lung parenchyma caused by COVID-19 infection.

View the entire article

Downloads

References

  1. Azer SA. COVID-19: pathophysiology, diagnosis, complications and investigational therapeutics. New Microbes New Infect 2020;37:100738. https://doi.org/10.1016/ j.nmni.2020.100738
  2. Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Public health: COVID-19 dashboard. Available from: https://systems.jhu.edu
  3. George P, Wells A, Jenkins R. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med 2020;8:807–815. https://doi.org/10.1016/ S2213-2600(20)30225-3
  4. Centers for Disease Control and Prevention. Post-COVID conditions: information for healthcare providers. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/late-sequelae.html
  5. Sun R, Liu H, Wang X. Mediastinal emphysema, giant bulla, and pneumothorax developed during the course of COVID-19 pneumonia. Korean J Radiol 2020;21(5):541–544. https://doi.org/10.3348/kjr.2020.0180
  6. Zoumot Z, Bonilla MF, Wahla AS, Shafq I, Uzbeck M, El Lababidi RM, et al. Pulmonary cavitation: an under-recognized late complication of severe COVID-19 lung disease. BMC Pulm Med 2021;21:24.
  7. Muheim M, Weber FJ, Muggensturm P, Seiler E. An unusual course of disease in two patients with COVID-19: pulmonary cavitation. BMJ Case Rep 2020;13(9):e237967.

Published

2021-12-29

Issue

Vol. 8 No. 12 (2021)

Categories

How to Cite

1.
Arias F, Chiappe A, Rey de Castro J, Zagacet J. Infected Cavitations, Bullae and Interstitial Lung Disease in a COVID-19 Patient in Lima, Peru. EJCRIM [Internet]. 2021 Dec. 29 [cited 2026 Nov. 3];8(12). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3004